145 related articles for article (PubMed ID: 8271386)
1. [Anti-HIV-1 p17 antibody as anti-HIV agent].
Tsuchie H; Tochikura A; Kageyama S; Kurimura T
Nihon Rinsho; 1993 Sep; 51 Suppl():213-8. PubMed ID: 8271386
[No Abstract] [Full Text] [Related]
2. Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17.
Kageyama S; Katsumoto T; Taniguchi K; Ismail SI; Shimmen T; Sasao F; Gao M; Owatari S; Wakamiya N; Tsuchie H; Ueda S; Shiraki K; Kurimura T
Acta Virol; 1996 Sep; 40(4):195-200. PubMed ID: 9014009
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
4. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
[TBL] [Abstract][Full Text] [Related]
5. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A
Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
Tewari D; Notkins AL; Zhou P
J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
[TBL] [Abstract][Full Text] [Related]
7. Use of the presence of anti-protein gag antibodies as an evolution marker of HIV infection.
Neguţ EA; Usein CR; Sfartz S; Zugun-Eloae F
Roum Arch Microbiol Immunol; 1999; 58(2):131-46. PubMed ID: 11845452
[TBL] [Abstract][Full Text] [Related]
8. Disappearance of anti-p17 correlates with successful isolation of human immunodeficiency virus and deterioration in clinical status.
Kageyama S; Kurimura T
Int J STD AIDS; 1990 Mar; 1(2):129-31. PubMed ID: 2092788
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS.
Fiorentini S; Giagulli C; Caccuri F; Magiera AK; Caruso A
Pharmacol Ther; 2010 Dec; 128(3):433-44. PubMed ID: 20816696
[TBL] [Abstract][Full Text] [Related]
10. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
[TBL] [Abstract][Full Text] [Related]
11. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
[TBL] [Abstract][Full Text] [Related]
12. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
[TBL] [Abstract][Full Text] [Related]
13. Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell.
Ota A; Liu X; Fujio H; Sakato N; Ueda S
Hybridoma; 1998 Feb; 17(1):73-5. PubMed ID: 9523241
[TBL] [Abstract][Full Text] [Related]
14. Immune complex transfer enzyme immunoassay for antibody IgM to HIV-1 p17 antigen.
Hashida S; Ishikawa S; Nishikata I; Hashinaka K; Oka S; Ishikawa E
J Clin Lab Anal; 1998; 12(6):329-36. PubMed ID: 9850183
[TBL] [Abstract][Full Text] [Related]
15. cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication.
Tewari D; Goldstein SL; Notkins AL; Zhou P
J Immunol; 1998 Sep; 161(5):2642-7. PubMed ID: 9725267
[TBL] [Abstract][Full Text] [Related]
16. Sensitive enzyme immunoassay of antibodies to HIV-1 p17 antigen using indirectly immobilized recombinant p17 for diagnosis of HIV-1 infection.
Ishikawa S; Hashinaka K; Hashida S; Oka S; Ishikawa E
J Clin Lab Anal; 1998; 12(6):343-50. PubMed ID: 9850185
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.
Mehta SU; Rupprecht KR; Hunt JC; Kramer DE; McRae BJ; Allen RG; Dawson GJ; Devare SG
AIDS Res Hum Retroviruses; 1990 Apr; 6(4):443-54. PubMed ID: 1692727
[TBL] [Abstract][Full Text] [Related]
18. [Preparation of a specific immunogen based on bacteriophage M13].
Minenkova OO; Il'ichev AA; Kishchenko GP; Il'icheva TN; Khripin IuL; Oreshkova SF; Petrenko VA
Mol Biol (Mosk); 1993; 27(3):561-8. PubMed ID: 7686250
[TBL] [Abstract][Full Text] [Related]
19. Identification of large glycosylated proteins recognized by monoclonal antibodies against HIV-1 gag proteins.
Pinter A; Honnen WJ; Revesz K; Herz R
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1341-4. PubMed ID: 1466953
[No Abstract] [Full Text] [Related]
20. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW
Clin Exp Immunol; 1995 Feb; 99(2):175-81. PubMed ID: 7851008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
